Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Financial Officer

See Remarks

Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, a peptidic inhibitor to treat patients with PD; SLS-008 for the treatment of pediatric indications; SLS-004 for the treatment of PD; SLS-010, an H3 receptor antagonist; and SLS-012. The company was founded in 2016 and is headquartered in New York, New York.

Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics fo...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-02-29	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-12-01	Premium	bought	Premium	Premium	Premium	See Remarks
2023-11-30	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2023-08-31	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-02-28	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2022-06-01	Premium	bought	Premium	Premium	Premium	-
2022-05-26	Premium	bought	Premium	Premium	Premium	-
2022-03-31	Premium	bought	Premium	Premium	Premium	See Remarks
2022-02-28	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2020-02-13	Premium	bought	Premium	Premium	Premium	See Remarks
2019-01-24	Premium	acquired	Premium	Premium	Premium	See Remarks

SEEL - Seelos Therapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for SEEL